← All organizations
Highest phase reached
Phase 3
First clinical trial
Jan 1, 2006First marketed drug
Jun 8, 2001First NDA
Mar 22, 2021Last known activity
Nov 25, 2025
Timeline
1990s
- Jan 1, 1998
Zealand Pharma— Founded
2020s
- Mar 22, 2021
dasiglucagon— Marketing Organization
- Mar 22, 2021
dasiglucagon— NDA Organization
- Mar 22, 2021
dasiglucagon— NDA Secondary Org
Drugs by trial phase (11 distinct, 44 trials)
Phase 3 (3 own, 0 via acquisition)
Phase 2 (5 own, 0 via acquisition)
Phase 1 (2 own, 0 via acquisition)
Other trials (1 own, 0 via acquisition)
Indications
Marketed drugs (1)
Recent trials (50)
- NCT07228403Lead sponsorPhase 3Nov 25, 2025
- NCT07197944Lead sponsorPhase 3Oct 23, 2025
- NCT06926842Lead sponsorPhase 2Apr 22, 2025
- NCT07076030Lead sponsorPhase 1Apr 15, 2025
- NCT06758583Lead sponsorPhase 1Dec 23, 2024
- NCT06662539Lead sponsorPhase 2Dec 6, 2024
- NCT06682975OfficialPhase 1Nov 30, 2024
- NCT06682975Lead sponsorPhase 1Nov 30, 2024
- NCT06000891Lead sponsorPhase 1Sep 15, 2023
- NCT05788601CollaboratorPhase 2Apr 27, 2023
- NCT05613387Study directorPhase 1Nov 7, 2022
- NCT05613387Lead sponsorPhase 1Nov 7, 2022
- NCT05378672Study directorPhase 3Jul 31, 2022
- NCT05378672Lead sponsorPhase 3Jul 31, 2022
- NCT05296733CollaboratorPhase 1Apr 27, 2022
Details
- Founded
- Copenhagen, DK Jan 1, 1998
- First NDA
- Mar 22, 2021
- Last known activity
- Nov 25, 2025